QuidelOrtho's 23.39% short interest is exceptionally elevated, creating structural squeeze potential if sentiment shifts, though the stock trades well below its 52-week high with an RSI of 37.8 suggesting room to recover from oversold conditions. The absence of a P/E ratio signals unprofitability, which explains the bearish positioning despite the modest $0.9B market cap. This combination—significant short exposure paired with negative earnings and depressed technicals—presents a high-risk, high-volatility setup where positive catalysts could trigger rapid covering, but fundamental concerns about the diagnostic company's path to profitability remain unresolved.
Snapshot
Recent headlines
Peers in In Vitro & In Vivo Diagnostic Substances
Build a thesis around QDEL
Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.
Open in AlgoThesis →